Advancing innovation and improving care for a stronger NHS

Health Innovation Oxford and Thames Valley supported our early evidence generation and health economic evaluation — providing critical insights into Dora’s clinical effectiveness, safety, and cost-efficiency. This early-stage support enabled us to demonstrate value to the NHS and build a strong foundation for wider adoption.

I am delighted to see the demonstrable improvement for patients resulting from this collaboration between the Health Innovation Oxford and Thames Valley patient safety team and our ward staff. The resulting culture change and improvements in patient experience and outcomes are worth celebrating and sharing widely.

The study has provided invaluable insights into the views of a wide range of stakeholders across the UK. This information not only supports the case for our AI tool, but it will enable barriers to implementation to be identified and addressed early.

Health Innovation Oxford and Thames Valley is a valued, trusted critically important partner of the ICB that delivers sustainable pathways of care through its skills and capability in enabling healthcare professionals and patients to adopt innovative solutions developed by universities and the life science industry.